HomeCompareASXC vs SBUX

ASXC vs SBUX: Dividend Comparison 2026

ASXC yields 574.88% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASXC wins by $183655.82M in total portfolio value
10 years
ASXC
ASXC
● Live price
574.88%
Share price
$0.35
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$183655.98M
Annual income
$136,833,479,194.82
Full ASXC calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — ASXC vs SBUX

📍 ASXC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASXCSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASXC + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASXC pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASXC
Annual income on $10K today (after 15% tax)
$48,864.62/yr
After 10yr DRIP, annual income (after tax)
$116,308,457,315.60/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, ASXC beats the other by $116,308,401,351.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASXC + SBUX for your $10,000?

ASXC: 50%SBUX: 50%
100% SBUX50/50100% ASXC
Portfolio after 10yr
$91828.07M
Annual income
$68,416,772,517.47/yr
Blended yield
74.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

ASXC
Analyst Ratings
2
Hold
Consensus: Hold
Price Target
$1.50
+331.2% upside vs current
Range: $1.50 — $1.50
Altman Z
-41.9
Piotroski
3/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASXC buys
0
SBUX buys
0
No recent congressional trades found for ASXC or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASXCSBUX
Forward yield574.88%2.75%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$183655.98M$157.5K
Annual income after 10y$136,833,479,194.82$65,840.13
Total dividends collected$179712.33M$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusHoldBuy
Analyst price target$1.50$104.00

Year-by-year: ASXC vs SBUX ($10,000, DRIP)

YearASXC PortfolioASXC Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$68,188$57,487.78$11,107$407.21+$57.1KASXC
2$439,313$366,351.83$12,512$626.87+$426.8KASXC
3$2,675,944$2,205,879.72$14,366$978.69+$2.66MASXC
4$15,420,706$12,557,445.87$16,929$1,557.50+$15.40MASXC
5$84,130,987$67,630,830.90$20,658$2,543.80+$84.11MASXC
6$434,856,205$344,836,049.27$26,406$4,302.22+$434.83MASXC
7$2,131,079,702$1,665,783,562.49$35,877$7,622.00+$2131.04MASXC
8$9,909,627,711$7,629,372,430.43$52,741$14,352.64+$9909.57MASXC
9$43,759,343,910$33,156,042,258.68$85,676$29,243.03+$43759.26MASXC
10$183,655,977,178$136,833,479,194.82$157,513$65,840.13+$183655.82MASXC

ASXC vs SBUX: Complete Analysis 2026

ASXCStock

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

Full ASXC Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this ASXC vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASXC vs SCHDASXC vs JEPIASXC vs OASXC vs KOASXC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.